<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7809373\results\search\disease\results.xml">
  <result pre="mediators to approximately pre-exposure concentration. This phenomena is caused by" exact="suppression" post="of expression levels of inflammatory molecules like tumour necrosis"/>
  <result pre="kidney and protecting kidney from cellular damage [22, 23]. The" exact="hyperuricemia" post="induced by lead acetate is possibly due to over-production"/>
  <result pre="9SohP.N.WitkowskiB.OlagnierD.In vitro and in vivo properties of ellagic acid in" exact="malaria" post="treatmentAntimicrob. Agents Chemother.5332009 Mar1100110619015354 10https://pubchem.ncbi.nlm.nih.gov/compound/ellagic_acid#section=Top 11BaeJ.Y.ChoiJ.S.KangS.W.LeeY.J.ParkJ.KangY.H.Dietary compound ellagic acid"/>
  <result pre="pathwayBiochim. Biophys. Acta Gen. Subj.1820102012 Oct 116931703 27RanaM.N.TangpongJ.RahmanM.A.Xanthones protects lead-induced" exact="chronic kidney disease" post="(CKD) via activating Nrf-2 and modulating NF-kB, MAPK pathwayBiochem."/>
 </snippets>
</snippetsTree>
